Kristina Hasselgren

Introduction: For patients with colorectal liver metastases (CRLM), the only treatment with a possibility for long-term survival and cure is radical resection. The majority of patients are at the time of diagnosis not assessed as resectable because they have advanced disease in the liver or unresectable extrahepatic disease or are too frail to withstand liver surgery. Patients who at the time of diagnosis are not assessed as resectable may be treated with conversion chemotherapy to downsize the tumor burden and render the patient eligible for resection. One concern with chemotherapy administered preoperatively has been the potential negative effect on the future liver remnant (FLR), especially for patients with a low volume of the FLR who are undergoing techniques to increase the volume. Established techniques to increase the volume are portal vein occlusion (PVO) and two-staged hepatectomy (TSH). A more recent method is Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS). Due to the relative novelty of ALPPS, the long-term oncological results are not known. For patients with CRLM, resection of liver metastases is more favorable from a health economic perspective than palliative treatment and results in a higher quality of life than palliative chemotherapy. For patients undergoing ALPPS as well as TSH, the data are scarce. Aim: The aim of the first study was to determine whether preoperative chemotherapy has a negative impact on the volume increase for patients undergoing ALPPS. The aim of the second study was to analyze the temporal course of the volume increase in the FLR for patients undergoing PVO. The aim of the third study was to study the long-term outcome for patients randomized to ALPPS or TSH. The aim of the fourth study was to perform a health economic analysis of patients randomized to ALPPS or TSH. Methods: The first study was based on data from the ALPPS registry, which is an international registry initiated 2012. All patients included in the registry between 2012 and 2016 were included. The patients were divided into the following four groups: no preoperative chemotherapy, 1 regimen of neoadjuvant chemotherapy, more than 1 regimen, and more than 1 regimen with the addition of monoclonal antibodies. The volume increase between interventions 1 and 2 was analyzed. In the second study, a retrospective analysis was performed of patients randomized to TSH. Forty-eight patients were included. The volume increase of the FLR was analyzed as the kinetic growth rate (KGR). The KGR was calculated from PVO until radical hepatectomy or exclusion, as well as between the first and second radiological evaluations. In the third and fourth studies, patients randomized to ALPPS and TSH were included. In the third study, survival, as well as factors affecting the outcome, were analyzed. In the fourth study, a calculation of resource use was performed, as was an analysis of health-related quality of life (HRQoL) for the groups. Results: In the first study, it was found that chemotherapy had no negative impact on the volume increase for patients undergoing ALPPS. In the second study, it was found that the volume increase of the FLR was largest the first week after ALPPS. In the third study, it was found that patients randomized to ALPPS had a longer survival than those randomized to TSH. Of the factors affecting the outcome, resection of liver metastases had a significant impact. In the fourth study, no significant difference could be found in resource use or HRQoL for patients randomized to ALPPS over TSH. Conclusion: Patients with advanced CRLM undergoing ALPPS should receive preoperative chemotherapy, if indicated. For those undergoing PVO, early evaluation is crucial to evaluate the volume increase, and for those with insufficient increase, additional techniques to increase the volume should be considered. Resection of liver metastases is an important factor to improve the outcome. Further studies are warranted to conclude whether ALPPS or TSH is most effective from a health economic perspective.

Colorectal Liver Metastases – Different Aspects on Treatment with Associated Liver Partition and Portal Vein Ligation for Staged Hepatectomy and on Portal Vein Occlusion

Mark Schaevers

Meredith Tax

From newspeak to nukespeak

Anna Carolina fortsätter att flyttas runt mellan olika familjer och barnhemmet. Mammor och pappor avlöser varandra och Anna Carolina gör som de vill, även om inte hon vill. Gör man inte som mammorna och papporna vill är man dum. Och är man du vill de inte ha med en att göra. Är man inte dum pratar de i alla fall med en. Trots att Anna Carolinas tillvaro är otrygg och består av nya människor hela tiden känner hon hopp. Skolan. Om man klarar skolan kan man tjäna egna pengar. Och när man blir vuxen klarar man sig själv. Man får bo alldeles för sig själv. "Känslokapitalisterna" är den tredje och avslutande boken i trilogin om fosterbarnet Anna Carolina. Den 15 maj år 1921 föds Anna Carolina Borggren. Hennes mor är Ragnhild Borggren och den finske sjömannen Atos Heikkonen är hennes far. Men det vet hon ingenting om. Trilogin om Anna Carolina följer om en ung fosterflicka genom hennes uppväxt och motgångar i ett tidigt 1900-tals Sverige. Kristina Hasselgren (1920-2003) var en svensk författare, journalist och modekonsult. Hon studerade film, litteratur och mode utomlands och arbetade sedan som modekonsult i Stockholm 1942-1963. Hon debuterade med boken Sandmålning 1956 och från och med 1971 arbetade hon som frilansande journalist och författare.

Kristina Hasselgren

About

Books

Join the club